What is Palvella Therapeutics's free cash flow?

Palvella Therapeutics (PVLA) reported free cash flow of -$2.74M in Q3 2024.

How has Palvella Therapeutics's free cash flow changed year-over-year?

Palvella Therapeutics's free cash flow increased by 72.0% year-over-year, from -$9.79M to -$2.74M.

What does free cash flow mean?

Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Palvella Therapeutics PVLA Free cash flow

Discontinued — last reported Q3 '24

Free cash flow at other companies

Relay Therapeutics, Inc.RLAY

-$44.87M+22.5%

Viridian Therapeutics, Inc.VRDN

-$119.68M-29.0%

ANI PharmaceuticalsANIP

$52.3M+60.8%

PrecigenPGEN

-$44.09M-160%

Arcutis Biotherapeutics, Inc.ARQT

$2.24M+107%

Kodiak Sciences IncKOD

-$40.95M-39.5%

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Calculated from Palvella Therapeutics’s reported figures.

−$2.7Mnet cash from operating−-capital expenditures=-$2.74M

The official record: Palvella Therapeutics’s 10-Q, filed November 12, 2025, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's free cash flow?: Palvella Therapeutics (PVLA) reported free cash flow of -$2.74M in Q3 2024.
How has Palvella Therapeutics's free cash flow changed year-over-year?: Palvella Therapeutics's free cash flow increased by 72.0% year-over-year, from -$9.79M to -$2.74M.
What does free cash flow mean?: Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.